Literature DB >> 8137778

Physiologically based toxicokinetic modeling of 1,3-butadiene lung metabolism in mice becomes more important at low doses.

C T Evelo1, J G Oostendorp, W F ten Berge, P J Borm.   

Abstract

This paper describes a physiologically based toxicokinetic model for 1,3-butadiene uptake, distribution, and metabolic clearance in mice. Model parameters for metabolic activity were estimated from the correspondence between computer simulation studies and experimental results as published in the literature. The parameterized model was validated with independent literature data. With the resulting model, the relative importance of lung metabolism as compared to metabolism in the liver increased with decreasing ambient air concentrations. This was due to saturation of metabolism in the alveolar area of the lung, which occurred in the simulations at ambient air concentrations well below current threshold limit values. At higher air concentration, liver metabolism became relatively more important. The tendency toward increased importance of lung metabolism at low doses indicates the necessity of careful extrapolation of in vivo results to low doses. Moreover, this trend may also contribute to species difference in susceptibility to the carcinogenic activity of butadiene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8137778      PMCID: PMC1519919          DOI: 10.1289/ehp.93101496

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  28 in total

1.  CARCINOGENICITY OF EPOXIDES, LACTONES, AND PEROXY COMPOUNDS.

Authors:  B L VANDUUREN; N NELSON; L ORRIS; E D PALMES; F L SCHMITT
Journal:  J Natl Cancer Inst       Date:  1963-07       Impact factor: 13.506

2.  Determination and prediction of tissue-gas partition coefficients.

Authors:  V Fiserova-Bergerova; M L Diaz
Journal:  Int Arch Occup Environ Health       Date:  1986       Impact factor: 3.015

3.  A physiologically based simulation approach for determining metabolic constants from gas uptake data.

Authors:  M L Gargas; M E Andersen; H J Clewell
Journal:  Toxicol Appl Pharmacol       Date:  1986-12       Impact factor: 4.219

4.  Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity/carcinogenicity study in rats.

Authors:  P E Owen; J R Glaister; I F Gaunt; D H Pullinger
Journal:  Am Ind Hyg Assoc J       Date:  1987-05

5.  Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues.

Authors:  M L Gargas; R J Burgess; D E Voisard; G H Cason; M E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  1989-03-15       Impact factor: 4.219

6.  Species differences in the formation of butadiene monoxide from 1,3-butadiene.

Authors:  U Schmidt; E Loeser
Journal:  Arch Toxicol       Date:  1985-09       Impact factor: 5.153

7.  Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.

Authors:  M E Andersen; H J Clewell; M L Gargas; F A Smith; R H Reitz
Journal:  Toxicol Appl Pharmacol       Date:  1987-02       Impact factor: 4.219

8.  Inhalation pharmacokinetics based on gas uptake studies. V. Comparative pharmacokinetics of ethylene and 1,3-butadiene in rats.

Authors:  H M Bolt; J G Filser; F Störmer
Journal:  Arch Toxicol       Date:  1984-10       Impact factor: 5.153

9.  Inhalation pharmacokinetics based on gas uptake studies. VI. Comparative evaluation of ethylene oxide and butadiene monoxide as exhaled reactive metabolites of ethylene and 1,3-butadiene in rats.

Authors:  J G Filser; H M Bolt
Journal:  Arch Toxicol       Date:  1984-10       Impact factor: 5.153

10.  Species differences in butadiene metabolism between mice and rats evaluated by inhalation pharmacokinetics.

Authors:  R Kreiling; R J Laib; J G Filser; H M Bolt
Journal:  Arch Toxicol       Date:  1986-04       Impact factor: 5.153

View more
  1 in total

Review 1.  The use of toxicologic data in mechanistic risk assessment: 1,3-butadiene as a case study.

Authors:  J A Bond; M W Himmelstein; M A Medinsky
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.